Merge pull request #272 from kerberos-io/revert/loopback

Revert/loopback

README.md

@@ -65,6 +65,7 @@ There are a myriad of cameras out there (USB, IP and other cameras), and it migh
 
 ### Contributing
 
+1. [Security vulnerability reporting](#security-vulnerability-reporting)
 1. [Contribute with Codespaces](#contribute-with-codespaces)
 2. [Develop and build](#develop-and-build)
 3. [Building from source](#building-from-source)
@@ -301,6 +302,10 @@ If we talk about video encoders and decoders (codecs) there are 2 major video co
 
 Conclusion: depending on the use case you might choose one over the other, and you can use both at the same time. For example you can use H264 (main stream) for livestreaming, and H265 (sub stream) for recording. If you wish to play recordings in a cross-platform and cross-browser environment, you might opt for H264 for better support.
 
+## Security vulnerability reporting
+
+If you found a potential security vulnerability, please use the private channels described in [SECURITY.md](SECURITY.md). Avoid opening public GitHub issues for sensitive findings.
+
 ## Contribute with Codespaces
 
 One of the major blockers for letting you contribute to an Open Source project is to set up your local development machine. Why? Because you might already have some tools and libraries installed that are used for other projects, and the libraries you would need for Kerberos Agent, for example FFmpeg, might require a different version. Welcome to dependency hell...

SECURITY.md

@@ -0,0 +1,40 @@
+# Security Policy
+
+## Supported Versions
+
+We only provide security fixes for the latest release series on the `master` branch.
+
+## Reporting a Vulnerability
+
+Please do **not** open a public GitHub issue for potential security vulnerabilities.
+
+Use one of the private channels below:
+
+1. Preferred: GitHub private vulnerability reporting
+   - https://github.com/kerberos-io/agent/security/advisories/new
+2. Fallback: Email
+   - support@kerberos.io
+   - Optional CC: support@uug.ai
+
+Please include:
+
+- A short summary and impact.
+- Reproduction steps or proof of concept.
+- Affected version(s), commit hash, or deployment details.
+- Any proposed mitigation/workaround.
+- Your preferred attribution name.
+
+For faster triage, use this subject format in email:
+
+`[Security][Kerberos Agent] <short title>`
+
+## Response Expectations
+
+- Acknowledgement target: within 3 business days.
+- Triage/update target: within 7 business days after acknowledgement.
+
+If you do not receive a response in time, please resend your report and include your original timestamp.
+
+## Disclosure and Credits
+
+We follow coordinated disclosure. After a fix is available, we will credit reporters unless they prefer to stay anonymous.

machinery/README.md

@@ -22,4 +22,8 @@ https://brianmacdonald.github.io/Ethonate/address#0xf4a759C9436E2280Ea9cdd23d314
 
 [**Docker Hub**](https://hub.docker.com/r/kerberos/agent) | [**Documentation**](https://doc.kerberos.io) | [**Website**](https://kerberos.io)
 
-Kerberos Open source (v3) is a cutting edge video surveillance management system made available as Open Source under the MIT License. This means that all the source code is available for you or your company, and you can use, transform and distribute the source code; as long you keep a reference of the original license. Kerberos Open Source (v3) can be used for commercial usage (which was not the case for v2). Read more [about the license here](LICENSE).
+Kerberos Open source (v3) is a cutting edge video surveillance management system made available as Open Source under the MIT License. This means that all the source code is available for you or your company, and you can use, transform and distribute the source code; as long you keep a reference of the original license. Kerberos Open Source (v3) can be used for commercial usage (which was not the case for v2). Read more [about the license here](LICENSE).
+
+## Security reporting
+
+For sensitive vulnerabilities, use private disclosure channels documented in [../SECURITY.md](../SECURITY.md).